Henry E. Pelish - Aug 29, 2025 Form 4 Insider Report for Nuvalent, Inc. (NUVL)

Role
Chief Scientific Officer
Signature
/s/ Nathan N. McConarty, attorney-in-fact
Stock symbol
NUVL
Transactions as of
Aug 29, 2025
Transactions value $
$4,986
Form type
4
Date filed
9/3/2025, 04:30 PM
Previous filing
Aug 8, 2025
Next filing
Sep 12, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Pelish Henry E. Chief Scientific Officer C/O NUVALENT, INC., ONE BROADWAY, 14TH FLOOR, CAMBRIDGE /s/ Nathan N. McConarty, attorney-in-fact 2025-09-03 0002029477

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NUVL Class A Common Stock Options Exercise $1.75K +2.01K +3.29% $0.87 63K Aug 29, 2025 Direct
transaction NUVL Class A Common Stock Options Exercise $3.24K +3K +4.76% $1.08 66K Aug 29, 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NUVL Stock Option (Right to Buy) Options Exercise $0 -2.01K -100% $0.00 0 Aug 29, 2025 Class A Common Stock 2.01K $0.87 Direct F1
transaction NUVL Stock Option (Right to Buy) Options Exercise $0 -3K -37.11% $0.00 5.09K Aug 29, 2025 Class A Common Stock 3K $1.08 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option are fully vested.